Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.160EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.160EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.160ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.160ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.182EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.182EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.182ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.182ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.182EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.182EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.182ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.182ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.430EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.430EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.430ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.430ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.430EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.430EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.430ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.430ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.331EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.331EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.331ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.331ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.331EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.331EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.331ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.331ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-7551.2South Korea
B.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-2308.74South Korea
B.19ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-12650.3Germany
B.19ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-11298.7Germany
B.19EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.19EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
B.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-11307.3China
B.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-13571.9China
AY.112.3 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.112.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.112.3 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.112.3 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.112.3 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.112.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.112.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.112.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.417EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.417EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.417ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.417ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.417EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.417EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used